Abstracts of the Joint Annual Meeting of the Swiss Society of Rheumatology and the Swiss Society of Physical Medicine and Rehabilitation

ABSTRACT

The proceedings contain 47 papers. The topics discussed include increased humoral immune response after vaccination with mRNA-1273 vs BNT162b2 in patients with inflammatory rheumatic diseases;comparison of anti-fracture effectiveness of denosumab versus bisphosphonates in a registry-based, real-world cohort study;comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in patients with rheumatoid arthritis who discontinued JAK inhibitor therapy;BRD3 regulates the inflammatory and stress response in rheumatoid arthritis synovial fibroblasts;effect of methotrexate and folic acid co-administration in arthritis;early anti-S antibody levels predict anti-SARS-CoV-2 neutralizing activity over 24 weeks in RA patients after SARS-CoV-2 mRNA vaccination;effect of zoledronate on bone mineral density and bone turnover markers after long-term denosumab therapy observations in a real-world setting;and developing a screening tool for the detection of interstitial lung disease in systemic sclerosis the ILD-RISC score.